Crossmark

Resveratrol for High Blood Pressure: A Total Failure or the Need to Identify the Right Patient?

Published Online: 2019-07-27

Published Print: 2019-10

Authors

Fogacci, Federica https://orcid.org/0000-0001-7853-0042
Fogacci, Silvia

Cicero, Arrigo
License Information

Text and Data Mining valid from 2019-07-27

Version of Record valid from 2019-07-27
More Information

Article History

Received: 21 July 2019

Accepted: 23 July 2019

First Online: 27 July 2019

Compliance with Ethical Standards

:

: Arrigo F. G. Cicero has given talks, furnished scientific consultancies and/or participated in trials sponsored by Amgen, Angelini, Menarini and Mylan; Federica Fogacci has served as consultant for Mylan and Roelmi HPC; Silvia Fogacci has no conflict of interest.

Document is current